Kids still dying from accidental exposure to fentanyl pain patches

Accidental exposure to fentanyl pain patches is putting children’s lives at risk, the U.S. Food and Drug Administration warns. Fentanyl is a powerful opioid pain reliever; so powerful that fentanyl patches are typically only prescribed to patients who require round-the-clock, long-term pain relief, such as cancer patients. They’re generally replaced every three days. Kids can […]

Continue Reading

Saving lives in Black barbershops

A new look at data from a landmark Cedars-Sinai study of health interventions in Black barbershops, and a new study that looks at barbershop patrons’ virtual visits with pharmacists, have added to the evidence that convenient, community-based health programs can cost-effectively control high blood pressure and prevent heart attack and stroke. A Landmark Study The […]

Continue Reading

New biomarkers may detect early eye changes that can lead to diabetes-related blindness

New biomarkers found in the eyes could unlock the key to helping manage diabetic retinopathy, and perhaps even diabetes, according to new research conducted at the Indiana University School of Optometry. During its early stages, diabetes can affect the eyes before the changes are detectable with a regular clinical examination. However, new retinal research has […]

Continue Reading

New approach for cell therapy shows potential against solid tumors with KRAS mutations

A new technology for cellular immunotherapy developed by Abramson Cancer Center researchers at Penn Medicine showed promising anti-tumor activity in the lab against hard-to-treat cancers driven by the once-considered ‘undruggable’ KRAS mutation, including lung, colorectal, and pancreatic. The study, published online in Nature Communications, successfully demonstrated using human cells that a T-cell receptor, or TCR, […]

Continue Reading

Better strategies needed for managing nonalcoholic fatty liver disease in adults

Effective screening, diagnosis, and management strategies are needed for patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), according to a special report published online July 26 in Gastroenterology. Fasiha Kanwal, M.D., from Baylor College of Medicine in Houston, and colleagues reviewed and discussed the literature on global burden, screening, risk stratification, diagnosis, […]

Continue Reading